Hervé Pegliasco

1.1k total citations
25 papers, 135 citations indexed

About

Hervé Pegliasco is a scholar working on General Health Professions, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hervé Pegliasco has authored 25 papers receiving a total of 135 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in General Health Professions, 8 papers in Public Health, Environmental and Occupational Health and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hervé Pegliasco's work include Palliative Care and End-of-Life Issues (8 papers), Health, Medicine and Society (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Hervé Pegliasco is often cited by papers focused on Palliative Care and End-of-Life Issues (8 papers), Health, Medicine and Society (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Hervé Pegliasco collaborates with scholars based in France, Italy and Canada. Hervé Pegliasco's co-authors include Anne Galinier, Yolande Obadia, Marc‐Karim Bendiane, Roger Favre, Patrick Peretti‐Watel, R. Favre, Patrick Lévy, Jean‐Louis Pépin, Sébastien Bailly and Marie Joyeux‐Faure and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and CHEST Journal.

In The Last Decade

Hervé Pegliasco

19 papers receiving 129 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hervé Pegliasco France 8 51 46 42 37 27 25 135
Aude Espinasse United Kingdom 6 35 0.7× 15 0.3× 23 0.5× 25 0.7× 3 0.1× 10 131
Ashley H. Tjaden United States 7 30 0.6× 25 0.5× 18 0.4× 12 0.3× 3 0.1× 25 151
Eta Ngole Mbong Cameroon 6 22 0.4× 17 0.4× 25 0.6× 4 0.1× 8 0.3× 16 153
Aline Priscila Batista Brazil 7 35 0.7× 14 0.3× 13 0.3× 14 0.4× 8 0.3× 18 114
Alberto Polo Italy 5 44 0.9× 58 1.3× 15 0.4× 6 0.2× 2 0.1× 6 154
Vinh Nguyen‐Nhu Vietnam 6 5 0.1× 104 2.3× 13 0.3× 109 2.9× 12 0.4× 25 183
Angela Mallozzi Canada 8 61 1.2× 91 2.0× 46 1.1× 55 1.5× 71 2.6× 10 303
Ireri Thirión-Romero Mexico 7 20 0.4× 55 1.2× 10 0.2× 52 1.4× 3 0.1× 25 184
Claude Earl Fox United States 5 25 0.5× 13 0.3× 30 0.7× 13 0.4× 7 0.3× 7 199
Jacquelien Noordhoek Netherlands 6 27 0.5× 32 0.7× 39 0.9× 151 4.1× 9 231

Countries citing papers authored by Hervé Pegliasco

Since Specialization
Citations

This map shows the geographic impact of Hervé Pegliasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Pegliasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Pegliasco more than expected).

Fields of papers citing papers by Hervé Pegliasco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Pegliasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Pegliasco. The network helps show where Hervé Pegliasco may publish in the future.

Co-authorship network of co-authors of Hervé Pegliasco

This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Pegliasco. A scholar is included among the top collaborators of Hervé Pegliasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Pegliasco. Hervé Pegliasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chiche, Laurent, et al.. (2025). Risk of Serious Immune-Related Adverse Events with Various PD1 and PD-L1 Inhibitors: A Single-Institution, Real-Life, Comparative Study. Therapeutics and Clinical Risk Management. Volume 21. 273–282.
2.
3.
Ciccolini, Joseph, Carlos Ayán Pérez, Sébastien Benzekry, et al.. (2024). 1380P PK/PD analysis of pembrolizumab, nivolumab and atezolizumab in NSCLC patients: The PIONeeR trial. Annals of Oncology. 35. S866–S867.
4.
Derosa, Lisa, Carolina Alves Costa Silva, Valerio Iebba, et al.. (2023). Friendly-user score assessing gut dysbiosis and resistance to immune checkpoint inhibitors (ICI).. Journal of Clinical Oncology. 41(16_suppl). 103–103. 2 indexed citations
5.
Debieuvre, D., I. Monnet, Olivier Bylicki, et al.. (2023). Two-year lung cancer survival between 2000 to 2020: Results from 3 French nationwide cohorts.. Journal of Clinical Oncology. 41(16_suppl). 8542–8542.
6.
Pénaranda, Guillaume, C. Stavris, F. Rétornaz, et al.. (2021). Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach. Therapeutics and Clinical Risk Management. Volume 17. 669–677. 9 indexed citations
7.
Halfon, Philippe, Guillaume Pénaranda, Hacène Khiri, et al.. (2021). An optimized stepwise algorithm combining rapid antigen and RT-qPCR for screening of COVID-19 patients. PLoS ONE. 16(9). e0257817–e0257817. 6 indexed citations
8.
Tamisier, Renaud, Erika Treptow, Marie Joyeux‐Faure, et al.. (2020). Impact of a Multimodal Telemonitoring Intervention on CPAP Adherence in Symptomatic OSA and Low Cardiovascular Risk. CHEST Journal. 158(5). 2136–2145. 24 indexed citations
9.
Chiche, Laurent, et al.. (2020). Une fixation pulmonaire au TEP-scan. La Revue de Médecine Interne. 42(3). 225–226.
10.
Roche, Nicolás, Manon Belhassen, Hervé Pegliasco, et al.. (2019). <p>Dual versus triple therapy in patients hospitalized for COPD in France: a claims data study</p>. International Journal of COPD. Volume 14. 1839–1854. 7 indexed citations
11.
12.
Roche, Nicolás, et al.. (2012). Multidimensional analyses to assess the relations between treatment choices by physicians and patients’ characteristics: the example of COPD. BMC Pulmonary Medicine. 12(1). 39–39. 1 indexed citations
13.
Fleury, Bernard, et al.. (2010). Traitement du SAHOS par orthèse d’avancée mandibulaire (OAM). Revue des Maladies Respiratoires. 27. S146–S156. 10 indexed citations
14.
Halfon, Philippe, F. Rétornaz, Didier Mathieu, et al.. (2009). Virus-associated hemophagocytic syndrome related to acute CMV and HBV sexual co-infection: A case report. Journal of Clinical Virology. 46(2). 189–191. 4 indexed citations
15.
Roche, Nicolás, et al.. (2009). Prise en charge de la BPCO en pneumologie selon le stade de sévérité. Revue des Maladies Respiratoires. 26(9). 933–941. 3 indexed citations
16.
Rétornaz, F., et al.. (2008). Une cause rare de douleurs thoraciques. La Revue de Médecine Interne. 30(2). 170–171.
17.
Bendiane, Marc‐Karim, Patrick Peretti‐Watel, Hervé Pegliasco, et al.. (2005). Morphine prescription to terminally ill patients with lung cancer and dyspnea: French physicians’ attitudes. Journal of Opioid Management. 1(1). 25–30. 8 indexed citations
18.
Galinier, Anne, et al.. (2005). Deux points de vue des médecins sur les soins palliatifs. Santé Publique. Vol. 17(1). 75–85. 4 indexed citations
19.
Peretti‐Watel, Patrick, Marc‐Karim Bendiane, Yolande Obadia, et al.. (2005). Disclosure of Prognosis to Terminally Ill Patients: Attitudes and Practices Among French Physicians. Journal of Palliative Medicine. 8(2). 280–290. 12 indexed citations
20.
Bendiane, Marc‐Karim, et al.. (2004). Opinions toward pain management and palliative care: Comparison between HIV specialists and oncologists. AIDS Care. 16(5). 619–627. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aude Espinasse Breakdown of academic impact, for papers by Ashley H. Tjaden Breakdown of academic impact, for papers by Eta Ngole Mbong Breakdown of academic impact, for papers by Aline Priscila Batista Breakdown of academic impact, for papers by Alberto Polo Breakdown of academic impact, for papers by Vinh Nguyen‐Nhu Breakdown of academic impact, for papers by Angela Mallozzi Breakdown of academic impact, for papers by Ireri Thirión-Romero Breakdown of academic impact, for papers by Claude Earl Fox Breakdown of academic impact, for papers by Jacquelien Noordhoek
Rankless by CCL
2026